Expert technical analysis of financial markets by JC Parets
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Coliseum Capital Management.
The hedge fund reported a purchase of roughly $5.3 million in MasterCraft Boat Holdings $MCFT, raising its ownership stake to 9.28%.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes by the CEO and one director of Agree Realty Corporation $ADC.
The two insiders filed separate Form 4s reporting ADC purchases with a combined value of $1.6 million.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Eli Samaha, founder and managing partner of Madison Avenue Partners LP.
Samaha reported a purchase of $558,528 in Synovus Financial Corp $SNV.
[Read more…]
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by RA Capital Management.
The investment firm reported a purchase of $8.1 million in the small-cap biotech company ARS Pharmaceuticals Inc $SPRY.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Broadwood Capital.
The firm reported a purchase of roughly $11.6 million in STAAR Surgical Company $STAA.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Jack Hightower, the chairman, president, and CEO of HighPeak Energy $HPK.
Hightower reported an HPK purchase worth a total of $8.4 million.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Berkshire Hills Bancorp Inc $BHLB director Mary Anne Callahan.
Callahan reported a purchase of $357,319 in BHLB.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.
The hedge fund reported a purchase of roughly $19.6 million in Ambrx Biopharma Inc $AMAM.
